-
Product Insights
Cerba HealthCare SAS Pipeline Insight and Competitive Landscape, 2023
Cerba HealthCare SAS (Cerba), is a biotechnology company that provides biological diagnosis solutions. The company provides medical biology laboratories and specialized biology laboratory programs. It conducts medical biology tests and clinical trials through its multidisciplinary platforms. Cerba offers services in the areas of anatomy, autoimmunity, allergology, cytogenetics, foetal biochemistry, sperm biochemistry, oncology, diabetology, endocrinology, enzymology, haemostasis, infectology, parasitology, and pathology, among others. The company offers services to doctors and pharmaceutical companies through its network of laboratories and collection centers. Cerba...
-
Sector Analysis
Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Next generation sequencing (NGS) refers to high-throughput methods for DNA sequencing that are not Sanger-based. NGS technology has largely superseded Sanger sequencing in academic or genome research and is increasingly being applied in clinical practice. The technique is highly scalable and typically involves fragmenting the genome and then randomly sampling for and sequencing these fragments. NGS can be performed on formalin-fixed and paraffin-embedded (FFPE) and freshly collected tissue specimens and on fine-needle aspiration samples and small biopsy specimens. The Next...
-
Product Insights
Yellow Fever Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2018" provides an overview of Yellow Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Yellow Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.